Challenges in Optimizing Treatment

  • Combining Immune Checkpoint Inhibition with Targeted Therapy: Ross Soo
  • Combining Immune Checkpoint Inhibition with Radiotherapy: Matthias Guckenberger
  • Moving Beyond PD-L1 / PD1 Targeting: Stefan Zimmermann
  • Discussion